Mengsha Tong

546 total citations
18 papers, 279 citations indexed

About

Mengsha Tong is a scholar working on Molecular Biology, Spectroscopy and Cancer Research. According to data from OpenAlex, Mengsha Tong has authored 18 papers receiving a total of 279 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 4 papers in Spectroscopy and 4 papers in Cancer Research. Recurrent topics in Mengsha Tong's work include Gene expression and cancer classification (6 papers), Bioinformatics and Genomic Networks (5 papers) and Advanced Proteomics Techniques and Applications (3 papers). Mengsha Tong is often cited by papers focused on Gene expression and cancer classification (6 papers), Bioinformatics and Genomic Networks (5 papers) and Advanced Proteomics Techniques and Applications (3 papers). Mengsha Tong collaborates with scholars based in China and United States. Mengsha Tong's co-authors include Xiangyü Li, Mengyao Li, Zheng Guo, Qingzhou Guan, Lu Ao, Haidan Yan, Hao Cai, Wei Chen, Lei Hong and Hao‐Hua Deng and has published in prestigious journals such as Scientific Reports, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease and Oncotarget.

In The Last Decade

Mengsha Tong

18 papers receiving 278 citations

Peers

Mengsha Tong
Bulin Du China
Dain Kim South Korea
Mengsha Tong
Citations per year, relative to Mengsha Tong Mengsha Tong (= 1×) peers Jiahao Qiu

Countries citing papers authored by Mengsha Tong

Since Specialization
Citations

This map shows the geographic impact of Mengsha Tong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengsha Tong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengsha Tong more than expected).

Fields of papers citing papers by Mengsha Tong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mengsha Tong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengsha Tong. The network helps show where Mengsha Tong may publish in the future.

Co-authorship network of co-authors of Mengsha Tong

This figure shows the co-authorship network connecting the top 25 collaborators of Mengsha Tong. A scholar is included among the top collaborators of Mengsha Tong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengsha Tong. Mengsha Tong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Liu, Yachen, et al.. (2024). Personalized analysis of human cancer multi-omics for precision oncology. Computational and Structural Biotechnology Journal. 23. 2049–2056. 4 indexed citations
2.
Tong, Mengsha, Zan Liu, Xin Wei, et al.. (2024). PhosMap: An ensemble bioinformatic platform to empower interactive analysis of quantitative phosphoproteomics. Computers in Biology and Medicine. 174. 108391–108391. 1 indexed citations
3.
Tong, Mengsha, et al.. (2024). SIMarker: Cellular similarity detection and its application to diagnosis and prognosis of liver cancer. Computers in Biology and Medicine. 171. 108113–108113. 2 indexed citations
5.
Yang, Zheng, Panyang Shen, Mengsha Tong, et al.. (2023). WISP2 downregulation inhibits the osteogenic differentiation of BMSCs in congenital scoliosis by regulating Wnt/β-catenin pathway. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1869(7). 166783–166783. 1 indexed citations
6.
Liu, Lifang, Muya Shu, Jianwu Dai, et al.. (2022). Complexity of enhancer networks predicts cell identity and disease genes revealed by single-cell multi-omics analysis. Briefings in Bioinformatics. 24(1). 5 indexed citations
7.
Yang, Wenxian, et al.. (2022). Application of individualized differential expression analysis in human cancer proteome. Briefings in Bioinformatics. 23(3). 5 indexed citations
8.
Li, Mingshuang, Yang Zheng, Weibin Du, et al.. (2022). Single‐cell RNA‐seq reveals altered NK cell subsets and reduced levels of cytotoxic molecules in patients with ankylosing spondylitis. Journal of Cellular and Molecular Medicine. 26(4). 1071–1082. 19 indexed citations
9.
Guo, Gaigai, et al.. (2020). NQO1 is a determinant for cellular sensitivity to anti-tumor agent Napabucasin.. PubMed. 10(5). 1442–1454. 7 indexed citations
10.
Tong, Mengsha, Chunyu Yu, Dongdong Zhan, et al.. (2018). Molecular subtyping of cancer and nomination of kinase candidates for inhibition with phosphoproteomics: Reanalysis of CPTAC ovarian cancer. EBioMedicine. 40. 305–317. 19 indexed citations
11.
Li, Mengyao, Guini Hong, Jun Cheng, et al.. (2016). Identifying Reproducible Molecular Biomarkers for Gastric Cancer Metastasis with the Aid of Recurrence Information. Scientific Reports. 6(1). 24869–24869. 15 indexed citations
12.
Guan, Qingzhou, Rou Chen, Haidan Yan, et al.. (2016). Differential expression analysis for individual cancer samples based on robust within-sample relative gene expression orderings across multiple profiling platforms. Oncotarget. 7(42). 68909–68920. 46 indexed citations
14.
Ao, Lu, Xiangyü Li, Mengsha Tong, et al.. (2016). An individualized prognostic signature and multi-omics distinction for early stage hepatocellular carcinoma patients with surgical resection. Oncotarget. 7(17). 24097–24110. 30 indexed citations
15.
Ao, Lu, Haidan Yan, Tingting Zheng, et al.. (2015). Identification of reproducible drug-resistance-related dysregulated genes in small-scale cancer cell line experiments. Scientific Reports. 5(1). 11895–11895. 11 indexed citations
16.
Li, Guangwen, Lei Hong, Mengsha Tong, et al.. (2015). Determination of tannic acid based on luminol chemiluminescence catalyzed by cupric oxide nanoparticles. Analytical Methods. 7(5). 1924–1928. 45 indexed citations
17.
Tong, Mengsha, Weicheng Zheng, Xingrong Lu, et al.. (2015). Identifying clinically relevant drug resistance genes in drug-induced resistant cancer cell lines and post- chemotherapy tissues. Oncotarget. 6(38). 41216–41227. 19 indexed citations
18.
Cai, Hao, Xiangyü Li, Jing Li, et al.. (2015). Tamoxifen therapy benefit predictive signature coupled with prognostic signature of post-operative recurrent risk for early stage ER+ breast cancer. Oncotarget. 6(42). 44593–44608. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026